M
Masakazu Yamagishi
Researcher at Osaka University of Human Sciences
Publications - 611
Citations - 19862
Masakazu Yamagishi is an academic researcher from Osaka University of Human Sciences. The author has contributed to research in topics: Percutaneous coronary intervention & Acute coronary syndrome. The author has an hindex of 62, co-authored 604 publications receiving 17939 citations. Previous affiliations of Masakazu Yamagishi include Kanazawa University & Toshiba.
Papers
More filters
Journal ArticleDOI
Clustering of Metabolic Syndrome Components Attenuates Coronary Plaque Regression During Intensive Statin Therapy in Patients With Acute Coronary Syndrome
Hiroaki Takashima,Yukio Ozaki,Takeshi Morimoto,Takeshi Kimura,Takafumi Hiro,Katsumi Miyauchi,Yoshihisa Nakagawa,Masakazu Yamagishi,Hiroyuki Daida,Tomofumi Mizuno,Kenji Asai,Yasuo Kuroda,Takashi Kosaka,Yasushi Kuhara,Akiyoshi Kurita,Kazuyuki Maeda,Tetsuya Amano,Masunori Matsuzaki +17 more
TL;DR: The JAPAN-ACS (Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome) trial as discussed by the authors showed that intensive statin therapy could induce significant coronary plaque regression in acute coronary syndrome (ACS).
Journal ArticleDOI
Impact of Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutation on the Occurrence of Chronic Pancreatitis in Japanese Patients
Hiroyuki Aoyagi,Toshihide Okada,Kenkei Hasatani,Hiroshi Mibayashi,Yoshiaki Hayashi,Shigetsugu Tsuji,Yoshibumi Kaneko,Masakazu Yamagishi +7 more
TL;DR: The CFTR gene mutation, especially the 5T genotype, appears to have some relationship to ICP prevalence in Japanese patients independent of cystic fibrosis.
Journal ArticleDOI
Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe.
Francesca Giordana,Antonio Montefusco,Fabrizio D'Ascenzo,Claudio Moretti,Silvia Scarano,Emad Abu-Assi,Sergio Raposeiras-Roubín,José P.S. Henriques,Jorge F. Saucedo,José Ramón González-Juanatey,Stephen B. Wilton,Wouter J. Kikkert,Iván J. Núñez-Gil,Albert Ariza-Solé,Xiantao Song,Dimitrios Alexopoulos,Christoph Liebetrau,Tetsuma Kawaji,Zenon Huczek,Shaoping Nie,Toshiharu Fujii,Luis C. L. Correia,Masa-aki Kawashiri,José María García-Acuña,Danielle A. Southern,Emilio Alfonso,Belén Terol,Alberto Garay,Dongfeng Zhang,Yalei Chen,Ioanna Xanthopoulou,Neriman Osman,Helge Möllmann,Hiroki Shiomi,Michal Kowara,Krzysztof J. Filipiak,Xiao Wang,Yan Yan,Jing-Yao Fan,Yuji Ikari,Takuya Nakahayshi,Kenji Sakata,Masakazu Yamagishi,Oliver Kalpak,Sasko Kedev,Fiorenzo Gaita +45 more
TL;DR: In the setting of the ACS, the new anti-platelets drugs appear to be safe and efficacious at mid-term follow-up independently from the geographic area.
Journal ArticleDOI
Impact of Phenyl Groups on Oxygen-bridged V-shaped Organic Semiconductors
Chikahiko Mitsui,Wataru Kubo,Yuji Tanaka,Masakazu Yamagishi,Tatsuro Annaka,Hiroaki Dosei,Masafumi Yano,Ken-ichi Nakamura,Daichi Iwasawa,Miki Hasegawa,Tsunayoshi Takehara,Takeyuki Suzuki,Hiroyasu Sato,Akihito Yamano,Jun Takeya,Toshihiro Okamoto +15 more
TL;DR: In this article, isomeric compounds of phenyl-substituted dinaphtho[2,3-b:2′,3′-d]furan were developed using a facile synthetic protocol.
Journal ArticleDOI
Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano-Ward syndrome under double mutations and acquired long QT syndrome under heterozygote.
Yusuke Fujii,Yuichi Matsumoto,Kenshi Hayashi,Wei-Guang Ding,Yukinori Tomita,Daisuke Fukumoto,Yuko Wada,Mari Ichikawa,Keiko Sonoda,Junichi Ozawa,Takeru Makiyama,Seiko Ohno,Masakazu Yamagishi,Hiroshi Matsuura,Minoru Horie,Hideki Itoh +15 more
TL;DR: Evaluating the genetic contribution of a KCNH2 variant for the two LQTS phenotypes concluded that even heterozygous carriers should be cared for not to encounter secondary factors because incidental factors could manifest "latent" form of p.His492Tyr.